The M. Leprosy RNA Detection Qualitative Test is a diagnostic assay designed to detect the RNA of the Mycobacterium leprae bacterium, which causes leprosy, also known as Hansen's disease. This advanced molecular test targets specific genetic material of the bacterium, providing a qualitative result that indicates the presence or absence of M. leprae RNA in the sample. The test is particularly useful for early diagnosis and for confirming suspected cases of leprosy, facilitating timely treatment and management of the disease.
Performed at DNA Labs UAE, a state-of-the-art facility known for its expertise in molecular diagnostics, the test ensures high sensitivity and specificity, minimizing the risk of false positives or negatives. The cost of the M. Leprosy RNA Detection Qualitative Test is set at 800 AED, reflecting the sophisticated technology and expertise involved in conducting the assay. This test represents a significant step forward in the fight against leprosy, offering a reliable tool for healthcare professionals in the diagnosis and control of this ancient disease.
The "Pan Enteric Bacteria RNA Detection Qualitative Test" is a sophisticated diagnostic procedure designed to identify the RNA signatures of a wide range of enteric bacteria in a patient's sample. This test is particularly valuable in the clinical setting for the rapid and accurate diagnosis of infections caused by bacteria that affect the gastrointestinal tract. Utilizing advanced molecular techniques, this test can detect the genetic material of various enteric pathogens, providing a qualitative assessment of their presence.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test ensures high sensitivity and specificity, making it a reliable tool for healthcare providers in the management of gastrointestinal infections. The cost of the test is set at 950 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed. By offering this test, DNA Labs UAE supports clinicians in making informed decisions regarding treatment strategies, ultimately improving patient outcomes in cases of bacterial enteric infections.
The "Plasmodium Species RNA Detection Qualitative Test" is a diagnostic procedure designed to identify the presence of RNA from Plasmodium species, which are the parasitic protozoans responsible for malaria. This test is particularly valuable in diagnosing malaria infections accurately and promptly, ensuring timely treatment. By targeting the RNA, the test can detect current infections, including those that may not be readily identifiable through traditional microscopy or antigen-based tests.
Performed at DNA Labs UAE, a leading facility in molecular diagnostics, this test employs advanced molecular techniques to ensure high sensitivity and specificity. The cost of the test is set at 950 AED, reflecting the sophisticated technology and expertise required to conduct such precise diagnostic procedures. The qualitative nature of the test means it provides a simple positive or negative result, indicating the presence or absence of Plasmodium RNA, thus facilitating immediate clinical decisions for the management of malaria.
Given the critical importance of early and accurate malaria diagnosis in preventing complications and controlling the spread of the disease, this test represents a vital tool in the healthcare arsenal against one of the world's most significant infectious diseases.
The Shigella Dysenterica RNA Detection Qualitative Test is a specialized diagnostic procedure designed to identify the presence of Shigella dysenteriae, the bacterium responsible for causing dysentery, particularly in regions with poor sanitation. This test specifically targets the RNA sequences unique to the Shigella dysenteriae pathogen, employing sophisticated molecular techniques to ascertain the presence or absence of the bacterium's genetic material in a patient's sample. This qualitative approach offers a high degree of specificity and sensitivity, making it an invaluable tool in the timely diagnosis and management of dysentery outbreaks.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and expert staff, this test ensures reliable results. The cost of the test is set at 950 AED, reflecting the sophisticated nature of the testing methodology and the expertise required to interpret the results. By opting for this test, healthcare providers can make informed decisions regarding the treatment and control of dysentery, ultimately contributing to improved patient outcomes and public health.
The Toxoplasma Gondii RNA Detection Qualitative Test is a diagnostic assay conducted to identify the presence of Toxoplasma gondii, a parasitic protozoan responsible for the infection toxoplasmosis, through the qualitative detection of its RNA. This test is particularly valuable in diagnosing acute infections and in monitoring the effectiveness of treatment in infected individuals. Utilizing advanced molecular techniques, this test offers a high degree of sensitivity and specificity for detecting the parasite's genetic material.
Administered at DNA Labs UAE, a leading facility in the region for genetic and molecular diagnostics, the test is priced at 950 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by highly trained professionals, ensuring accurate and reliable results. The test is recommended for individuals suspected of having an active Toxoplasma infection, especially pregnant women, immunocompromised patients, and those experiencing symptoms related to toxoplasmosis. Given the potential health risks associated with Toxoplasma gondii, especially in vulnerable groups, this test plays a crucial role in timely diagnosis and management of the infection.
The "FISH - 11q23 or LSI MLL Gene Breakapart Test" is a sophisticated diagnostic procedure aimed at detecting chromosomal abnormalities related to the MLL (Mixed Lineage Leukemia) gene, located on chromosome 11q23. This test is particularly significant in the diagnosis and management of various types of leukemia, where rearrangements involving the MLL gene play a crucial role in the disease's development and progression. By utilizing Fluorescence In Situ Hybridization (FISH) technology, this test can precisely identify the presence of breakaparts or rearrangements in the MLL gene, providing essential information for accurate diagnosis, prognosis, and treatment planning.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities, the test offers a reliable and efficient solution for healthcare providers and patients dealing with leukemia. The cost of the test is set at 950 AED, reflecting the intricate technology and expertise involved in conducting this specialized genetic analysis. Through the FISH - 11q23 or LSI MLL Gene Breakapart Test, DNA Labs UAE continues to contribute to the advancement of personalized medicine, enabling targeted treatment approaches based on the genetic makeup of individual patients.
The FISH - 14q32.3 or LSI IGH Gene Breakapart Test is a sophisticated diagnostic procedure utilized to detect chromosomal abnormalities, specifically translocations involving the immunoglobulin heavy chain (IGH) gene located at the 14q32.3 locus. This test is particularly relevant in the diagnosis and management of various hematologic malignancies, such as multiple myeloma and certain types of non-Hodgkin lymphoma, where the rearrangement of the IGH gene plays a critical role in the disease's pathogenesis.
Fluorescence in situ hybridization (FISH) technology is employed in this test, allowing for the visualization of genetic abnormalities at a molecular level. This technique uses fluorescent probes that bind to specific DNA sequences of interest, in this case, the IGH gene, enabling the detection of gene rearrangements that may not be visible through conventional cytogenetic methods.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers a high level of accuracy and reliability. The cost of the FISH - 14q32.3 or LSI IGH Gene Breakapart Test is 1010 AED. This investment is invaluable for patients requiring precise diagnosis and treatment planning for conditions associated with the IGH gene rearrangements, providing crucial information that can guide therapeutic decisions and potentially improve patient outcomes.
The FISH (Fluorescence In Situ Hybridization) - c-MYC Amplification Test is a specialized diagnostic procedure conducted at DNA Labs UAE. This test is designed to detect amplifications of the c-MYC gene, which can play a crucial role in the development and progression of various cancers, including breast, colon, and lung cancers. The c-MYC gene is known for its role in cell cycle progression, apoptosis, and cellular transformation, making its amplification a significant marker for oncology diagnostics.
The procedure utilizes fluorescence in situ hybridization technology, where fluorescently labeled DNA probes are used to target and bind to specific regions of the c-MYC gene within a patient's chromosomal DNA. The presence of amplified c-MYC signals is then visualized under a fluorescence microscope, providing a direct observation of genetic anomalies at the molecular level.
The cost of the FISH - c-MYC Amplification Test at DNA Labs UAE is 1010 AED. This investment covers the technical expertise, advanced laboratory equipment, and specialized reagents required to accurately detect and quantify c-MYC gene amplifications. The test results can offer critical insights for personalized cancer treatment plans, helping healthcare providers to tailor therapies that target the specific genetic alterations driving the malignancy.
Given its importance in the diagnostic landscape of oncology, the FISH - c-MYC Amplification Test is a valuable tool for clinicians in the management and treatment of cancer patients, ensuring a more targeted and effective approach to cancer care.
The FISH (Fluorescence In Situ Hybridization) - del13q or LSI D13S319 test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to detect the deletion of the long arm of chromosome 13, specifically at the D13S319 locus, which is a common genetic abnormality found in various hematological malignancies, including chronic lymphocytic leukemia (CLL) and multiple myeloma. The test utilizes fluorescent probes to bind to specific DNA sequences on chromosome 13, allowing for the visualization of genetic alterations under a fluorescence microscope.
The presence of a deletion at the 13q14 locus, where D13S319 is located, can have prognostic implications, influencing treatment decisions and patient management. This test is particularly important in the clinical assessment of individuals suspected of having or diagnosed with related cancers, providing valuable information on the genetic makeup of the malignancy.
The cost of the FISH - del13q or LSI D13S319 Test at DNA Labs UAE is 1010 AED. The procedure is carried out in a state-of-the-art laboratory setting by skilled technicians, ensuring accurate and reliable results. DNA Labs UAE is known for its commitment to quality and precision in genetic testing, making it a trusted choice for patients and healthcare providers seeking comprehensive genetic diagnostics.
The FISH (Fluorescence In Situ Hybridization) - inv16 or LSI CBFB Test is a specialized genetic test performed to detect the inversion of chromosome 16, specifically targeting the CBFB gene. This particular genetic alteration is commonly associated with certain types of leukemia, most notably acute myeloid leukemia (AML). The test utilizes fluorescent probes to bind to specific DNA sequences on chromosome 16, allowing for the visualization of the inversion under a fluorescence microscope.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test is pivotal in the diagnosis and management of patients suspected of having or known to have leukemia. By identifying the inv16 or CBFB gene rearrangement, clinicians can better determine prognosis, tailor treatment plans to the individual patient, and monitor response to therapy.
The cost of the FISH - inv16 or LSI CBFB Test at DNA Labs UAE is 1010 AED. Given the complexity of the test and the specialized equipment and expertise required, this cost reflects the comprehensive analysis and reliable results provided by the laboratory. Patients and healthcare providers considering this test should consult with a specialist to understand its implications fully and how it fits into the broader diagnostic and treatment plan.
